secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2025-04-04T23:59:59+00:00
Accession:  0001213900-25-029002
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar receives Nasdaq delisting notice for bid price below $1.00
-----------------------------------------------------------------

- Received Nasdaq notice on April 3, 2025 for non-compliance with minimum bid price rule.
- Must regain compliance by September 30, 2025; closing bid price must be at least $1.00 for 10 consecutive days.
- If not compliant by deadline, Nasdaq may grant second 180-day grace period subject to conditions.
- Company intends to monitor bid price and consider options to regain compliance; no guarantee of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390025029002/0001213900-25-029002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390025029002/ea0237178-8k_nektar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-029002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer